Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Reliability and Validity of Three DT-TUG Protocols in MS

24 augusti 2026 uppdaterad av: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Comparison of the Reliability and Convergent Validity of Three Dual-Task Timed Up and Go Protocols in People With Multiple Sclerosis

Dual-tasking is performing two different tasks at the same time. For example, singing while cooking. Everyday activities often involve dual-task. In many researches evaluating dual-task performance in individuals with MS, it has been reported that individuals with severe disability, in particular, exhibit greater effort than healthy individuals. This increase in motor and cognitive dual-task performance in individuals with Multiple Sclerosis (MS) is associated with an increased risk of falls. There is a need for standardized, valid, and reliable assessment tools to evaluate dual-task performance in MS. The purpose of this study is to examine and compare the validity and reliability of the dual-task Timed Up and Go test administered using three different protocols.

Studieöversikt

Status

Rekrytering

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Dual-tasking is performing two different tasks at the same time. For example, singing while cooking. Everyday activities often involve dual-task. In many researches evaluating dual-task performance in individuals with MS, it has been reported that individuals with severe disability, in particular, exhibit greater effort than healthy individuals. This increase in motor and cognitive dual-task performance in individuals with MS is associated with an increased risk of falls. There is a need for standardized, valid, and reliable assessment tools to evaluate dual-task performance in MS. The purpose of this study is to examine and compare the validity and reliability of the dual-task Timed Up and Go test (DTUG) administered using three different protocols. To this end, this study will evaluate the validity and reliability of the DTUGs-which consist of three subtasks: counting backward in threes, verbal fluency, and ball-carrying on a tray-and compare their clinical applicability relative to one another. For validity analyses, convergent validity will be assessed. For reliability analyses, intra- and inter-rater reliability will be assessed, and SEM and MDC values will be calculated. Additionally, Bland-Altman plots will be plotted for intra- and inter-rater agreement analyses.

Studietyp

Observationell

Inskrivning (Beräknad)

40

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

Studieorter

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Participants will be recruited from among individuals who visit the outpatient clinic of the Department of Neurology at SANKO University.

Beskrivning

Inclusion Criteria:

  • Having been diagnosed with MS according to the McDonald criteria revised in 2017,
  • Being between the ages of 18 and 65,
  • Having an Expanded Disability Status Scale (EDSS) score between 0 and 5.5,
  • Not requiring any assistive walking devices.

Exclusion Criteria:

  • Pregnancy;
  • Having experienced a relapse within the past three months;
  • The presence of another neurological condition in addition to MS;
  • The presence of a different disorder that could potentially affect gait parameters;
  • The presence of visual, auditory, perceptual, or cognitive impairments severe enough to interfere with the test administration

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Patients with Multiple Sclerosis
Patients with Multiple Sclerosis aged between 18-65 years
Övrig: Intra-rater reliability analysis
For the intra-rater reliability analysis, three DTUG protocols will be evaluated at 7- to 10-day intervals.
Övrig: Inter-rater reliability analysis
For the inter-rater reliability analysis, three DTUG protocols will be administered to the same patient by two different physical therapists.
Övrig: Convergent validity
To assess convergent validity, the relationship between the measurements from the three DTUG protocols and the results of other balance and functional mobility tests will be examined.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Dual-task Timed up and go test (DTUG)
Tidsram: A single assessment will be administered to all participants at the end of the study. The assessment takes approximately 5 minutes.
The DTUG task will be evaluated in three different ways. The primary task will consist of the Timed Up and Go (TUG) test. The TUG test involves standing up from a chair, walking 3 meters, turning around, and sitting back down. While this test is being administered, secondary tasks will be performed simultaneously, and the time taken to complete the test will be recorded. The secondary tasks consist of a three-count backward counting task, verbal fluency, and a ball-carrying task on a tray.
A single assessment will be administered to all participants at the end of the study. The assessment takes approximately 5 minutes.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Afyonkarahisar Health Sciences University

Utredare

  • Huvudutredare: Emel TAŞVURAN HORATA, PhD, Afyonkarahisar Health Sciences University
  • Studiestol: Hakan POLAT, PhD, Sanko University
  • Studiestol: Meltem UZUN, PhD, Sanko University
  • Studiestol: Suat EREL, PhD, Pamukkale University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

16 mars 2026

Primärt slutförande (Beräknad)

14 september 2026

Avslutad studie (Beräknad)

14 september 2026

Studieregistreringsdatum

Först inskickad

24 augusti 2026

Först inskickad som uppfyllde QC-kriterierna

24 augusti 2026

Första postat (Faktisk)

27 augusti 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

27 augusti 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

24 augusti 2026

Senast verifierad

1 augusti 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2026/02-1

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera